<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="6495">Lipoprotein</z:chebi>(a) [Lp(a)] level is a newly established vascular risk factor which has been suggested to play a role in <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the majority of Lp(a) cell-to-cell interactions are mediated by its specific <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi>(a) [apo(a)] moiety </plain></SENT>
<SENT sid="2" pm="."><plain>This suggests that the size polymorphism of apo(a) may be of importance in conveying the Lp(a)-related risk </plain></SENT>
<SENT sid="3" pm="."><plain>Specifically, we postulated that variation in apo(a) isoform size may lead to increased risk of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD), <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), <z:hpo ids='HP_0001297'>stroke</z:hpo>, or <z:hpo ids='HP_0000001'>all</z:hpo> three of them </plain></SENT>
<SENT sid="4" pm="."><plain>Under a case-control design we compared Lp(a) plasma levels and the distribution of apo(a) phenotypes in groups of subjects consisting of 50 VaD patients, 162 <z:hpo ids='HP_0003745'>sporadic</z:hpo> AD patients, 95 non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> <z:hpo ids='HP_0001297'>stroke</z:hpo> patients (NDS), and 105 <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="5" pm="."><plain>The prevalence of small-sized apo(a) isoforms in the VaD group was significantly higher than that in the <z:hpo ids='HP_0001297'>stroke</z:hpo> and <z:mpath ids='MPATH_458'>normal</z:mpath> control groups, with an odds ratio of 5.29 (95% CI 2.24-12.49, p = 0.0001) for the development of VaD for individuals with at least one apo(a) isoform of low molecular weight (LMW) </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, the possession of at least one small-sized apo(a) isoform significantly increased the risk of AD to 1.92 (95% CI 1.02-3.61, p = 0.0434) </plain></SENT>
<SENT sid="7" pm="."><plain>Our results demonstrate that possession of at least one LMW apo(a) isoform is significantly associated with <z:hpo ids='HP_0000726'>dementia</z:hpo> and specifically offer new evidence of a strong association between the <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> system and post-<z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>